Rothschild Investment LLC’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Buy
259
+127
+96% +$5.33K ﹤0.01% 1670
2026
Q1
$4.25K Buy
132
+8
+6% +$296 ﹤0.01% 2143
2025
Q4
$5.22K Buy
124
+4
+3% +$161 ﹤0.01% 1857
2025
Q3
$4.12K Sell
120
-20
-14% -$574 ﹤0.01% 1793
2025
Q2
$3.78K Buy
140
+5
+4% +$145 ﹤0.01% 1648
2025
Q1
$4K Buy
135
+20
+17% +$762 ﹤0.01% 1538
2024
Q4
$4.55K Buy
115
+20
+21% +$757 ﹤0.01% 1382
2024
Q3
$3.23K Buy
95
+45
+90% +$1.27K ﹤0.01% 1470
2024
Q2
$1.08K Buy
50
+45
+900% +$946 ﹤0.01% 1622
2024
Q1
$111 Buy
+5
New +$122 ﹤0.01% 2168

Other funds holding VCYT

Rothschild Investment LLC's VCYT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Veracyte (VCYT) stake by 96% in Q2 2026, buying an estimated $5.33K and bringing the position to 259 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Rothschild Investment LLC first reported a position in VCYT in Q1 2024 and has held it in 10 quarters since. 151 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Rothschild Investment LLC held 259 shares of Veracyte worth $15.2K as of Q2 2026.
  • Rothschild Investment LLC bought 127 Veracyte shares in Q2 2026, an estimated $5.33K.
  • Veracyte made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1670 holding.
  • Rothschild Investment LLC first reported a position in Veracyte in Q1 2024 and has held it in 10 quarters since.
  • 151 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.